A Look at FDA’s Gene and Cell Therapy Framework and its Impact on New Hemophilia Treatments in 2021 and Beyond
More cell and gene therapy products are being developed and entering clinical trials each year. The U.S. Food and Drug Administration plays a key role in overseeing drug development, including providing guidance and receiving investigational new drug applications or requests to start a new clinical trial submitted by drug developers. In 2021, there are more than […]
COVID-19 Vaccines Don't Stop Emerging Therapy Options for Those with Bleeding Disorders
By HFA Staff with scientific review by Dr. David Clark and Dr. Lisa HensleyMany people have questions about the COVID-19 vaccines. This article will answer one primary question: Can getting vaccinated for COVID-19 cut off treatment options for emerging bleeding disorder treatments and therapies? Of the three vaccines currently available in the United States, the […]